High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.4M
$1,368,852
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RAPP
M
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
Other
2026-02-19
$10,800
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-19 | $10,800 | M | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-17
$246,655x3
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-17 | $246,655x3 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-01-15
$228,132x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-01-15 | $228,132x2 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-15
$255,130x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-12-15 | $255,130x2 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-11-17
$214,091x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-11-17 | $214,091x2 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-10-15
$219,196x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-10-15 | $219,196x2 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-09-15
$205,649x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-09-15 | $205,649x2 | S | Form 4 |